We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

52 hedge funds and large institutions have $12.6M invested in Forte Biosciences in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

64% more call options, than puts

Call options by funds: $568K | Put options by funds: $346K

0.35% more ownership

Funds ownership: 1.11% → 1.46% (+0.35%)

1% less capital invested

Capital invested by funds: $12.8M → $12.6M (-$162K)

9% less funds holding

Funds holding: 57 → 52 (-5)

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

Holders
52
Holders Change
-5
Holders Change %
-8.77%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
17
Reduced
10
Closed
19
Calls
$568K
Puts
$346K
Net Calls
+$222K
Net Calls Change
+$1.7M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.96M
2
Two Sigma Investments
Two Sigma Investments
New York
+$794K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$683K
4
Citadel Advisors
Citadel Advisors
Florida
+$529K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$415K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$603K
2
WP
Woodline Partners
California
-$424K
3
OQS
Occudo Quantitative Strategies
Florida
-$417K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$412K
5
Jane Street
Jane Street
New York
-$312K
Name Holding Trade Value Shares
Change 		Change in
Stake
HSBC Holdings
26
HSBC Holdings
United Kingdom
$28K +$34.3K +510 New
AWM
27
Aries Wealth Management
Maine
$28K +$35K +520 New
Squarepoint
28
Squarepoint
New York
$28K +$35.3K +525 New
UBS Group
29
UBS Group
Switzerland
$25K +$30.2K +449 +3,742%
State Board of Administration of Florida Retirement System
30
State Board of Administration of Florida Retirement System
Florida
$24K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$21K – – –
Wells Fargo
32
Wells Fargo
California
$16K -$14K -208 -42%
CG
33
Cutler Group
California
$13K -$25.5K -379 -59%
AIG
34
American International Group
New York
$13K -$471 -7 -3%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$13K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$10K +$2.02K +30 +19%
JP Morgan Chase
37
JP Morgan Chase
New York
$9K – – –
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$7K +$5.11K +76 +165%
Citigroup
39
Citigroup
New York
$5K +$3.23K +48 +91%
Federated Hermes
40
Federated Hermes
Pennsylvania
$4K +$4.44K +66 New
Legal & General Group
41
Legal & General Group
United Kingdom
$3K – – –
CAPTRUST Financial Advisors
42
CAPTRUST Financial Advisors
North Carolina
$3K +$202 +3 +6%
AIP
43
Ameritas Investment Partners
Nebraska
$2K – – –
EW
44
Evoke Wealth
California
$2K +$2.29K +34 New
Osaic Holdings
45
Osaic Holdings
Arizona
$1K +$942 +14 +280%
TWC
46
TD Waterhouse Canada
Ontario, Canada
$214 +$269 +4 New
WP
47
Woodline Partners
California
– -$424K -5,724 Closed
OQS
48
Occudo Quantitative Strategies
Florida
– -$417K -5,632 Closed
Jane Street
49
Jane Street
New York
– -$312K -4,643 Closed
GCP
50
GSA Capital Partners
United Kingdom
– -$152K -2,051 Closed
1
2
3

FBRX Hedge Fund Activity: Q4 2021 in Review

52 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q4 2021, worth a combined $12.6M — down 1.3% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of FBRX and 14 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 17 added.

The largest buyer was Morgan Stanley, adding an estimated $2.96M. The largest seller was Millennium Management, cutting an estimated $603K.

  • 52 institutional investors held Forte Biosciences (FBRX) as of Q4 2021, down from 57 in Q3 2021.
  • Funds reported $12.6M of Forte Biosciences stock for Q4 2021, down 1.3% quarter-over-quarter.
  • 14 funds opened new Forte Biosciences positions in Q4 2021 and 19 closed out, a net change of -5 holders.
  • The largest Forte Biosciences buyer in Q4 2021 was Morgan Stanley, an estimated $2.96M added.
  • The largest Forte Biosciences seller in Q4 2021 was Millennium Management, an estimated $603K sold.

Based on aggregated 13F filings for Q4 2021.